FASN and obesity disorder: Consistent with its observed anti‐obesity action in older mice, rimonabant markedly decreased mRNA levels of the lipogenic gene fatty acid synthase (FAS) by 4‐fold (P < 0.05) in aged epididymal fat tissue (Fig. 6B).